Baxter
(NYSE: BAX)
will shutter its manufacturing facility in Acton, Massachusetts.
In a statement shared with MassDevice, the company said: “We made the difficult decision to close manufacturing operations at our Acton location. We are moving these operations to another facility within Baxter’s integrated supply chain network. We appreciate our Acton-based colleagues’ dedication and service and are providing transition benefits to impacted employees.”
Baxter is letting go of 59 workers as a result of the facility closure, according to a WARN notice filed with the state of Massachusetts. The layoffs are effective May 3 to Jun 30.
According to local media reports, Baxter acquired the Acton facility through its $12.5 billion purchase of Hillrom in 2021.
More than a year ago, the company announced a cost reduction program. The Deerfield, Illinois-based company — maker of renal care products, drug delivery devices and more — said it needed to cut costs to respond to what it described as significant macroeconomic challenges. The costs reductions including cutting 5% of the company’s global workforce, a reduction that could affect up to 3,000 jobs.
CEO José (Joe) E. Almeida said at the time: “We will take these necessary steps with the utmost care and sensitivity, in full knowledge that the passion and commitment of our Baxter team drives our success. We are poised to emerge transformed for a new era, better positioned to compete in the dynamic healthcare marketplace and create value for our stakeholders.”
